Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.

被引：0
|
作者：
Tsuji, Takayuki
Kawakubo, Hirofumi
Takeuchi, Masashi
Matsuda, Satoru
Fukuda, Kazumasa
Nakamura, Rieko
Kitagawa, Yuko
机构：
[1] Keio Univ, Sch Med, Shinjuku Ku, Tokyo, Japan
[2] Keio Univ, Div Gen & Gastroenterol Surg, Sch Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
362
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [1] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
    Yoshinami, Yuri
    Yamamoto, Shun
    Kadono, Toru
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 373 - 373
  • [2] Efficacy and safety of endoscopic submucosal dissection in elderly patients with esophageal squamous cell carcinoma.
    Shin, In Seub
    Song, Byeong Geun
    Kim, Doyeon
    Lee, Hyuk
    Min, Byung-Hoon
    Lee, Jun Haeng
    Rhee, Poong-Lyul
    Kim, Jae J.
    Min, Yang Won
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [3] The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
    Shiraishi, Kazuhiro
    Okada, Mao
    Yamamoto, Shun
    Matsubara, Yuki
    Masuishi, Toshiki
    Shimozaki, Keitaro
    Yamamoto, Yoshiyuki
    Hirose, Suguru
    Sugiyama, Keiji
    Furuta, Mitsuhiro
    Machida, Nozomu
    Takahashi, Naoki
    Yoshii, Takako
    Kito, Yosuke
    Tsuzuki, Takao
    Boku, Shogen
    Tsuchihashi, Kenji
    Sugaya, Akinori
    Takayama, Toshizo
    Komori, Azusa
    Mitani, Seiichiro
    Matsumoto, Toshihiko
    Nishimura, Takashi
    Hirata, Kenro
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [4] Safety and efficacy of nivolumab therapy in patients with advanced esophageal squamous cell carcinoma
    Shimada, Seitaro
    Tsushima, Takahiro
    Shirasu, Hiromichi
    Kawakami, Takeshi
    Hamauchi, Satoshi
    Todaka, Akiko
    Yokota, Tomoya
    Yamazaki, Kentaro
    Fukutomi, Akira
    Onozawa, Yusuke
    Yasui, Hirofumi
    ANNALS OF ONCOLOGY, 2021, 32 : S328 - S328
  • [5] Defining conversion therapy for esophageal squamous cell carcinoma
    Matsuda, Satoru
    Tsushima, Takahiro
    Kato, Ken
    Hsu, Chih-Hung
    Lee, Jang Ming
    Wong, Ian Yu-Hong
    Wang, Hu-Lin Christina
    Kang, Chang Hyun
    Guo, Xufeng
    Yamamoto, Shun
    Tsuji, Takayuki
    Kawakubo, Hirofumi
    Takeuchi, Hiroya
    Law, Simon
    Kitagawa, Yuko
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (01): : 7 - 9
  • [6] The efficacy and safety of toripalimab combined with definitive chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma.
    Xi, Mian
    Zhu, Yujia
    Li, Qiao-Qiao
    Zhao, Lei
    Yang, Yadi
    Hu, Yonghong
    Liu, Mengzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Efficacy and safety of apatinib with or without radiotherapy as second-line or beyond therapy in patients with advanced/recurrent esophageal squamous cell carcinoma.
    Lv, Jiahua
    Li, Tao
    Wang, Qifeng
    Fan, Yu
    Wang, Junchao
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Efficacy and safety of endostar in the treatment of advanced lung squamous cell carcinoma.
    Hu, Weiheng
    Fang, Jian
    Nie, Jun
    Dai, Ling
    Zhang, Jie
    Chen, Xiaoling
    Ma, Xiangjuan
    Tan, Guangming
    Wu, Di
    Han, Jindi
    Han, Sen
    Wang, Yang
    Long, Jieran
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] The efficacy and safety of neoadjuvant sintilimab combined with chemotherapy in elderly patients with locally advanced esophageal squamous cell carcinoma.
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 378 - 378
  • [10] The overall safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yoshinami, Yuri
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kashiraha, Tairo
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Igaki, Hiroshi
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 329 - 329
12345